{
    "Trade/Device Name(s)": [
        "Acro Rapid THC (Marijuana) Urine Test",
        "Acro Rapid (THC) Marijuana Urine Test"
    ],
    "Submitter Information": "Acro Biotech LLC",
    "510(k) Number": "K053034",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ"
    ],
    "Summary Letter Date": "June 6, 2006",
    "Summary Letter Received Date": "April 10, 2006",
    "Submission Date": "April 10, 2006",
    "Regulation Number(s)": [
        "21CFR862.3870"
    ],
    "Regulation Name(s)": [
        "Cannabinoid test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Tetrahydrocannabinol (THC)"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow",
        "One-step immunoassay"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Acro Rapid THC (Marijuana) Urine Test, a lateral flow immunoassay for qualitative detection of THC in urine",
    "Indications for Use Summary": "Qualitative detection of Tetrahydrocannabinol (THC) in human urine at a cutoff of 50 ng/mL for laboratory use; provides preliminary results requiring further confirmation",
    "fda_folder": "Toxicology"
}